Sun Pharma and Taro Reach Definitive Merger Agreement
Sun Pharmaceutical Industries will purchase Taro’s outstanding shares for $43 each, which will total $348 million.
October 24, 2026
Sun Pharmaceutical Industries will purchase Taro’s outstanding shares for $43 each, which will total $348 million.